Core Insights - KKR & Co is holding its first board meeting in Asia in Tokyo, highlighting Japan's significance for the firm [1] - Japan has become KKR's largest market in Asia, with investments totaling over $20 billion, accounting for 36% of its total fair value in the region [3] Investment Activity - KKR has been consistently investing in Japan for nearly two decades, with private equity-backed deals reaching $29 billion in the first three quarters of 2025, a 150% increase year-on-year [2] - Recent acquisitions include Hoken Minaoshi Hompo Group and Fuji Soft for $4.1 billion, along with a partnership to acquire Topcon for $2.3 billion [3][4] Market Context - The dealmaking boom in Japan is driven by corporate governance reforms, low interest rates, and heightened investor interest [2] - KKR's sale of a controlling stake in the Seiyu supermarket chain for $2.55 billion in March reflects successful investment returns [4] Board Composition - KKR's board includes notable figures such as Evan Spiegel, Patricia Russo, and Robert Scully, indicating a diverse leadership [5]

Core Insights - Bank of America has appointed Geoff Iles and Lukas Poensgen as co-heads of mergers and acquisitions in Europe, the Middle East, and Africa [1][2] - The appointments come as EMEA dealmaking shows signs of revival, with transaction values increasing by 11% this year to approximately $950 billion [3] Leadership Changes - Geoff Iles has been with Bank of America since 2003 and has led UK M&A for the past seven years; he will be based in London [1][2] - Lukas Poensgen joined the bank in 2010 and has been leading M&A in Germany, Austria, and Switzerland; he will be based in Frankfurt [1][2] Market Context - Bank of America ranks sixth among advisers in the EMEA region with a market share of 9.7% [3] - The increase in deal value indicates a potential recovery in the M&A market, which could present new opportunities for investment [3] Notable Transactions - Iles advised on Centamin Plc's £1.9 billion ($2.6 billion) sale to Anglogold Ashanti Plc and worked on International Paper Co.'s acquisition of DS Smith Plc [4] - Poensgen was involved in PAI Partners' sale of Apleona Group GmbH to Bain Capital, valuing the company at around €4 billion ($4.7 billion), and the sale of a €2 billion stake in IFCO to Stonepeak Partners [5]

Core Viewpoint - Dorf Ketal is in advanced negotiations to acquire Italmatch Chemicals SpA for $1.6 billion, marking its largest acquisition to date and reflecting a consolidation trend in the specialty chemicals industry [14][15]. Company Overview - Dorf Ketal, founded in 1992, is a leading manufacturer and supplier of specialty chemicals, focusing on the hydrocarbons chemicals value chain, including oil and gas exploration, refining, and petrochemicals [14][15]. - The company reported a domestic revenue of ₹5,479 crore in FY24, with revenue for the first half of FY25 reaching ₹2,961.3 crore [14][15]. Acquisition Rationale - The acquisition of Italmatch is aimed at diversifying into adjacent markets and expanding the product and service offerings [5][15]. - Italmatch operates in four key segments: water and oil treatment, lubricants, flame retardants and plastic additives, performance products, and personal care, which aligns with Dorf Ketal's strategic goals [5][15]. Financial Performance - Italmatch reported FY24 revenue of €686 million, with an 8% increase in sales volumes year-over-year. Adjusted EBITDA rose 17% from €115 million to €134 million, and contribution margin increased by 10% to €276 million [8][15]. - Italmatch has maintained a stable EBITDA margin of 20-21% despite challenges in the global chemicals market [10][15]. Strategic Growth - Dorf Ketal has a history of growth through acquisitions, having made at least a dozen since 2003, enhancing its R&D capabilities and product knowledge [7][10]. - The company has expanded its footprint to Latin America, focusing on sustainable chemistries derived from plant-based sources [7][15]. Market Context - The global specialty chemicals market has grown from $1.03 trillion in 2021 to $1.14 trillion in 2023, with projections to reach $1.43 trillion by 2028, driven by demand from various end-use industries [13][15]. - The ongoing challenges in the chemical sector, particularly in Europe, may lead to more favorable pricing for buyers in the current market environment [13][15].

Registration No. 333-290126 Table of Contents As filed with the U.S. Securities and Exchange Commission on September 17, 2025. (State or Other Jurisdiction of Incorporation or Organization) Cayman Islands 6770 98-1853296 (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identification Number) 200 Clarendon Street Boston, Massachusetts 02116 Tel: +1 (617) 516-2000 (Address, Including Zip Code, and Telephone Number, Including Area Code, of Registrant's Principal Executive Offices) UNIT ...

Bankers have lined up around €600 million ($710 million) of debt financing to back Bain Capital’s acquisition of Dutch technology services company HSO https://t.co/crqJYP4atm ...

Group 1: Company Overview - Bristol-Myers Squibb Company (NYSE:BMY) is a global biopharmaceutical leader specializing in oncology, immunology, cardiovascular, hematology, and neuroscience therapies, with notable drugs such as Eliquis and Opdivo [1] - The company has launched a new independent biotech focused on autoimmune disease therapies, funded with $300 million, retaining a 20% stake [2] Group 2: Recent Developments - BMY is advancing immunotherapy for lung cancer, with a Phase II trial showing a 76% tumor reduction rate for BNT327/pumitamig, now in Phase III trials supported by a collaboration valued at up to $11.1 billion [3] - A clinical trial for Iza-bren, an investigational breast cancer therapy, was launched in July 2025, targeting patients unsuitable for conventional immunotherapies [4] Group 3: Financial Performance - In Q2 2025, Eliquis sales rose 8% to $3.7 billion, while Opdivo revenue grew 7% to $2.6 billion, indicating strong revenue from established products alongside an expanding pipeline [5]

Core Insights - Mogo Inc. has appointed Joanna Floyd to its Board of Directors, enhancing its leadership team with her extensive experience in global financial services [1] Company Overview - Joanna Floyd has a strong background in organizational leadership and talent management, having previously worked at Bain Capital and Lehman Brothers [1] - She began her career in mergers and acquisitions at Deutsche Bank, indicating a solid foundation in financial operations [1] - Currently, she serves as Partner and COO of Th, further showcasing her leadership capabilities [1]

Core Insights - The AGIX index aims to capture the beta and alphas of the AGI era, which is expected to be a significant technological paradigm shift over the next 20 years, similar to the impact of the internet on society [1] - The article emphasizes the importance of learning from legendary investors like Warren Buffett and Ray Dalio to navigate this unprecedented technological revolution [1] Market Performance - AGIX outperformed major US indices with a weekly return of 3.15%, year-to-date return of 25.69%, and a return of 69.95% since 2024 [2] - In comparison, the S&P 500 and QQQ had returns of 1.37% and 1.35% respectively for the week [2] Sector Performance - The performance of various sectors for the week was as follows: - Semi & hardware: 0.93% with a weight of 23% - Infrastructure: 2.23% with a weight of 45% - Application: -0.01% with a weight of 32% [3] AI Developments - Nebius Group signed a $17.4 billion agreement with Microsoft to provide GPU infrastructure over five years, highlighting the surge in demand for high-performance AI computing [14][15] - Microsoft is diversifying its AI capabilities by incorporating Anthropic technology into Office 365, indicating a shift from reliance on OpenAI [15] - Nvidia launched the Rubin CPX GPU, designed for large-scale AI applications, which is expected to significantly enhance performance [17] Financial Insights - Adobe raised its revenue guidance, expecting quarterly revenue between $6.08 billion and $6.13 billion, driven by AI product contributions [18] - Micron Technology's stock price increased after Citi raised its target price to $175, reflecting positive market sentiment and expectations for strong performance in the upcoming quarters [19] ETF Insights - ETFs receive dividends from the stocks they hold, which are then distributed to ETF holders after deducting relevant fees [20] - The process of dividend distribution involves several steps, including the payment of dividends by the underlying companies and the aggregation of these dividends by the ETF management [21]

AI Boom Fuels $5.6 Billion Data Center Bain Capital, Vantage Deals Across China And Malaysiahttps://t.co/MvCXov8boP https://t.co/EJ1DSu2tP8 ...

Core Viewpoint - Bain Capital has agreed to sell its Chinese data centre business, WinTriX DC Group, in a transaction valued at $4 billion, marking the largest M&A deal in China's data centre industry history [1][2]. Group 1: Transaction Details - The acquisition will be led by a consortium headed by Shenzhen Dongyangguang Industry (HEC), which includes institutional investors such as insurance companies and local government funds [2]. - The deal is expected to conclude in the first quarter of next year, pending regulatory approval [5]. Group 2: Company Background - WinTriX DC Group's China operations, known as Chindata, have become a significant hyperscale data centre platform since 2018, playing a crucial role in China's digital transformation [3]. - Chindata is recognized as one of China's leading digital infrastructure platforms, boasting unmatched scale and technical capabilities [4]. Group 3: Financial Insights - ByteDance is the largest customer of WinTriX, accounting for 86% of its revenue in 2022, as reported by Fitch Ratings [5].